Figure A (Obizur 01)
Obizur Kit
Product Images NDC 0944-5001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Obizur (NDC 0944-5001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure B (Obizur 02)
Figure C (Obizur 03)
Figure D (Obizur 04)
Figure E (Obizur 05)
Figure F (Obizur 06)
Figure G (Obizur 07)
Figure H (Obizur 08)
Figure I (Obizur 09)
Principal Display Panel (Kit Carton)
This is a description of OBIZUR, a recombinant antihemophilic factor made from porcine sequence. It comes in a single-dose vial as a lyophilized powder for intravenous administration after reconstitution. The product contains no preservative and is sterile and nonpyrogenic. It should be stored at a temperature between 2°C to 8°C and not beyond the expiration date. The package includes a vial adapter, diluent, and a package insert that provides dosage and administration information. The product is not made with natural rubber latex.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
